Sabinsa Corporation
Sabinsa Corporation is a US-headquartered B2B manufacturer of standardized botanical extracts, patented branded nutraceutical and cosmeceutical ingredients, and specialty chemicals, serving dietary supplement, personal care, pharmaceutical, and food manufacturers across 100+ countries from facilities in India and the US.
- Company typePrivate
- Founded1988
- HeadquartersLong Island City, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sabinsa Corporation does
Sabinsa Corporation is a US-headquartered, research-driven manufacturer and B2B supplier of standardized botanical extracts, phytochemicals, cosmeceutical actives, specialty and fine chemicals, and proprietary branded nutraceutical ingredients. Founded in 1988 by Dr. Muhammed Majeed in New Jersey and anchored by its 1991-vintage Indian operating arm (Sami-Sabinsa Group in Bengaluru), Sabinsa vertically integrates tissue-culture cultivation, supercritical fluid and continuous extraction, probiotic and enzyme fermentation, analytical R&D with mass spectrometry and liquid chromatography, and contract manufacturing. The company markets more than 120 branded ingredients, including BioPerine, Curcumin C3 Complex, ForsLean, Boswellin/Boswellin Super, LivLonga, Livinol, Citrin, Cococin, DigeZyme, Sabroxy, Tinofolin, CurCousin, Saberry, Cirpusins, Momordicin, GS4 PLUS, Cinnasil, pTeroSol, and Bacopin, supported by 500+ global patents and an extensive clinical publication record.
The company operates eight or more manufacturing facilities across India (Bengaluru, Kunigal, Hassan, Nelamangala, Dobaspete, Hyderabad) and the United States (Payson, Utah), employs 1,400+ people including 120+ research scientists, and reaches 100+ countries through 14+ wholly-owned regional subsidiaries in the US, Canada, Brazil, Australia, China, Japan, Korea, Vietnam, Germany, Poland, South Africa, and the UAE, plus a Jebel Ali Free Zone distribution hub. Regulatory assets include GRAS affirmations, novel food authorization in the EU and Great Britain, NSF GMP and FSSC 22000 certifications, and EFSA opinions, providing documented dossiers that anchor ingredient claims for downstream formulators.
Sabinsa's revenue model combines one-time ingredient sales across five streams (nutraceutical ingredients, cosmeceutical ingredients, specialty/fine chemicals, licensing and patent royalties on branded extracts, and contract manufacturing services). B2B quote-based pricing is delivered through direct sales teams with localized formulation and technical support. Customer segments span nutraceutical and dietary supplement manufacturers (primary), cosmeceutical and personal care manufacturers (primary), pharmaceutical companies, and food and beverage manufacturers. The company is privately held, founder-family-owned following Dr. Majeed's passing in March 2024, and is currently led by Dr. Anju Majeed (Group Executive Chairperson), Shaheen Majeed (Global CEO & Managing Director), Asha Ramesh (CEO Americas), and Madhu Subramanian (President, Global Business Expansion and Operations). Recent strategic actions include the February 2025 acquisition of Nature's Formulary and the 2026 novel food authorization for Curcumin C3 Reduct in Great Britain.
Sabinsa Corporation firmographics
Firmographics- Name
- Sabinsa Corporation
- Legal name
- Sabinsa Corporation
- Website
- https://sabinsa.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Sabinsa Corporation is a US-headquartered B2B manufacturer of standardized botanical extracts, patented branded nutraceutical and cosmeceutical ingredients, and specialty chemicals, serving dietary supplement, personal care, pharmaceutical, and food manufacturers across 100+ countries from facilities in India and the US.
- Ownership category
- akta.pro rank
Sabinsa Corporation industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
- akta.pro primary industry
- Herbal & Botanical Supplements (CRADAGAD)
- akta.pro secondary industry
- Weight Management & Metabolic Supplements (CRADAGAG)
Keywords
Where Sabinsa Corporation is headquartered
LocationHeadquarters
- HQ city
- Long Island City
- HQ country
- United States
- HQ region
- North America
Offices19 records
Markets served
Sabinsa Corporation business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Nutraceutical Ingredients: Sale of standardized botanical extracts and phytochemicals for dietary supplements and functional foods. Products include standardized phyto extracts, multi-enzyme blends, probiotics, prebiotics, postbiotics, and synbiotics.
- Cosmeceutical Ingredients: Supply of natural actives, peptides, anti-glycation ingredients, dermaceuticals, and nutricosmetics for personal care and cosmetic formulations.
- Specialty Chemicals and Fine Chemicals: Manufacturing and sale of specialty chemicals, organic intermediates, and nutritional fine chemicals for pharmaceutical and food industries.
- Licensing and Patents: Royalties from patented ingredients including BioPerine, ForsLean, and other proprietary branded extracts. Over 500 global patents with licensing opportunities.
- Contract Manufacturing: Custom and contract manufacturing services for finished supplement products from GMP facilities in Utah, USA and India.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Sabinsa Corporation product offering
Product offeringCore offering
Sabinsa Corporation manufactures and supplies standardized botanical extracts, phytochemicals, cosmeceutical actives, specialty fine chemicals, enzymes, probiotics, and related branded ingredients to business customers in the nutraceutical, dietary supplement, cosmetic/personal care, pharmaceutical, and food & beverage industries. The company operates a vertically integrated model spanning cultivation, extraction, standardization, and formulation support, complemented by custom and contract manufacturing services from GMP-certified facilities in the US and India.
Product overview
Sabinsa Corporation is a research-driven multinational health science company and leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, biotics, and enzymes for the nutritional, cosmetic, pharmaceutical, and food industries. The company offers a portfolio of over 120 branded ingredients including standardized phytoextracts (Boswellin, BioPerine, ForsLean, Citrin, Cococin, Bacopin), multi-enzyme blends (DigeZyme), microbiome products (Prebiotics, Probiotics, Postbiotics & Synbiotics), liver support formulations (LivLonga, Livinol), and cognitive health ingredients (Sabroxy, Tinofolin). Cosmeceutical offerings include Natural Actives, Peptides, Dermaceuticals, and Nutricosmetics. The company provides custom and contract manufacturing services alongside its ingredient portfolio. Key branded ingredients include Curcumin C3 Complex, BioPerine, Boswellin, ForsLean, Citrin, Cococin, Bacopin, GS4 PLUS, Momordicin, Cinnasil, pTeroSol, DigeZyme, Tinofolin, Sabroxy, CurCousin, Saberry, Cirpusins, LivLonga, Livinol, and Boswellin Super, with recent expansion including Curcumin C3 Reduct for the European and Great Britain markets.
Differentiator
Problem solved
Functional benefit
Brands
- BioPerine: Patented black pepper extract standardized for minimum 95% Piperine, used as a bioavailability enhancer for over 35 years
- Curcumin C3 Complex
- LivLonga
- Boswellin Super
- Saberry
- Boswellin
- Citrin
- CurCousin
- Sabroxy
- Tinofolin
- Livinol
- DigeZyme
- pTeroSol
- Cinnasil
- ForsLean
- Momordicin
- GS4 PLUS
- Bacopin
- Cococin
- Cirpusins
Products and services
- Standardized Phyto Extracts
Quantifiable outcome
- 98 publications with 72+ clinical studies for BioPerine alone
- +3 more outcomes
Companies that use Sabinsa Corporation
Customer profileSegments4 records
Ideal customer profiles3 records
Sabinsa Corporation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Sabinsa Corporation partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Nature's FormularycoreSabinsa acquired Nature's Formulary, an Ayurvedic supplement company based in the USA. This acquisition expands Sabinsa's presence in the dietary supplement industry by leveraging Nature's Formulary's expertise and market reach, representing vertical integration into finished product retail.
Scale indicators13 records
Recent moves6 records
Expansion highlights7 records
Sabinsa Corporation competitors and assessment
Company assessmentMarket position
Competitive moat7 records
Key risks5 records
Key highlights7 records
Customer concentration
Sabinsa Corporation social profiles
Digital presenceSabinsa Corporation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sabinsa Corporation leadership team
Management profileNumber of profiles
Profiles6 records
Sabinsa Corporation subsidiaries and ownership
Company hierarchySubsidiaries14 records
Sabinsa Corporation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sabinsa Corporation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sabinsa Corporation
What does Sabinsa Corporation do?
Sabinsa Corporation manufactures and supplies standardized botanical extracts, phytochemicals, cosmeceutical actives, specialty fine chemicals, enzymes, probiotics, and related branded ingredients to business customers in the nutraceutical, dietary supplement, cosmetic/personal care, pharmaceutical, and food & beverage industries. The company operates a vertically integrated model spanning cultivation, extraction, standardization, and formulation support, complemented by custom and contract manufacturing services from GMP-certified facilities in the US and India.
Is Sabinsa Corporation a public or private company?
Sabinsa Corporation is a private company. It is classified as family owned and is currently operating.
When was Sabinsa Corporation founded?
Sabinsa Corporation was founded in 1988. It employs 1,001 to 5,000 people.
Where is Sabinsa Corporation based?
Sabinsa Corporation is headquartered in Long Island City, United States, in the North America region.
How does Sabinsa Corporation make money?
Five revenue lines are on record. Nutraceutical Ingredients are the primary driver. The others are cosmeceutical Ingredients, specialty Chemicals and Fine Chemicals, licensing and Patents and contract Manufacturing.
Does Sabinsa Corporation have an API?
No public API is recorded for Sabinsa Corporation.
What industry is Sabinsa Corporation in?
Sabinsa Corporation's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of CRADAGAG, Weight Management & Metabolic Supplements. Its NAICS code is 325411 and its SIC code is 2833.